Abstract
Get full access to this article
View all access options for this article.
References
1.
Mor
A
Mitnick
HJ
Pillinger
MH
Wortmann
RL
. Drug-induced myopathies . Bull NYU Hosp Jt Dis
2009 ; 67 : 358 –369 .
2.
Casado
E
Gratacós
J
Tolosa
C
. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients . Ann Rheum Dis
2006 ; 65 : 385 –390 .
3.
Estes
ML
Ewing-Wilson
D
Chou
SM
. Chloroquine neuromyotoxicity. Clinical and pathologic perspective . Am J Med
1987 ; 82 : 447 –455 .
4.
Kwon
JB
Kleiner
A
Ishida
K
. Hydroxychloroquine-induced myopathy . J Clin Rheumatol
2010 ; 16 : 28 –31 .
5.
Abdel-Hamid
H
Oddis
CV
Lacomis
D
. Severe hydroxychloroquine myopathy . Muscle Nerve
2008 ; 38 : 1206 –1210 .
6.
Bolaños-Meade
J
Zhou
L
Hoke
A
. Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease . Am J Hematol
2005 ; 78 : 306 –309 .
7.
Siddiqui
AK
Huberfeld
SI
Weidenheim
KM
. Hydroxychloroquine-induced toxic myopathy causing respiratory failure . Chest
2007 ; 131 : 588 –590 .
8.
Mateen
FJ
Keegan
BM
. Severe, reversible dysphagia from chloroquine and hydroxychloroquine myopathy . Can J Neurol Sci
2007 ; 34 : 377 –379 .
9.
Costedoat-Chalumeau
N
Hulot
JS
Amoura
Z
. Cardiomyopathy related to antimalarial therapy with illustrative case report . Cardiology
2007 ; 107 : 73 –80 .
10.
Amato
AA
Barohn
RJ
. Evaluation and treatment of inflammatory myopathies . J Neurol Neurosurg Psychiatry
2009 ; 80 : 1060 –1068 .